Lifeboat Foundation

What do you think of this new idea?

Flying in the face of a funding ban, research centers move ahead with developing human-animal chimeras.

Read more

Bone-foam is about to make broken bones a thing of the past.

Read more

As we explore opportunities in space to colonized or even expand business opportunities in space such as mining, and discovering materials that could be brought back to earth to use; it will be important for scientists and researchers to look at ways in how technologies like CRISPR, nanobots, synthetic implants, etc. can assist in mitigating the impacts on humans in space.

A new report commissioned by NASA highlights many of the risks connected with one of the agency’s major goals: putting more humans in space for longer periods of time.

Read more

The MMTP is testing Senolytics in an ambitious large scale mouse longevity project.

The goal of regenerative medicine is both quantity and quality whilst traditional medicine has provided quantity often at the cost of quality. Regenerative medicine proposes to reduce the frailty and decline of old age by rejuvenating the body and promoting healthy longevity. With advances in technology, research and our understanding of the aging process, this is now becoming a realistic proposition.

Some drugs already tested have been found to increase mouse lifespan such as Metformin ^1,2 and Rapamycin ³.These drugs are even now moving into human clinical trials to see if the above benefits translate into people. However, there are many more promising substances that have never been properly tested and we do not know if they could extend healthy lifespan.

Continue reading “Major Mouse Testing To Fast Track Regenerative Medicine” »

Truly a potential bummer for Car-T as a result of the risk in creating immune defiancy disease such as CRS.

A win and loss for marijuana, a big advance in Alzheimer’s disease, and the next big thing are among some of the market-moving things I expect to see happen this year.

Read more

Carl Zimmer, a science journalist, explains how the revolutionary new genome-editing tool CRISPR works.

Zimmer is a columnist for The New York Times and the author of “A Planet of Viruses.”

Continue reading “Carl Zimmer explains the CRISPR DNA editing system in 90 seconds” »

A new class of sound wave has been developed for the first time in 50 years that could revolutionize the use of stem cells in medical treatments.

This new class can be used as a “supervaccine” that can deliver vaccines and other medicines directly to the lungs in record time.

Read more

Dr Millers paper here hits the nail on the head for me about aging research and how we can speed it up.

“The time spent by gerontologists debating whether aging is a single process or many would be better devoted to trying to figure out the mechanistic links between the master clock whose existence is strongly suggested by the unitarian argument and the many cell-specific, organ-specific, and organism-wide processes that march in crude synchrony at species-specific rates.”

Yes! This is exactly the attitude to take. Too much debate and argument instead of buckling down and getting the research done to prove or disprove aging hypotheses. Cut to the chase and lets just do it.

Continue reading “The historical assumption has been that, human aging is a natural process, and one that is non optional with regard to medical interventions” »

Analyzing expressions is an increasingly hot topic among tech companies.

It’s not clear what it plans to do with it yet, but Apple has gobbled up a startup whose technology can read facial expressions.

The tech giant has reportedly acquired Emotient, a San Diego-based company that uses artificial technology to detect emotion from facial expressions, Apple confirmed to The Wall Street Journal. The company’s technology has primarily been used by advertisers, doctors, and retailers, though it’s not clear what Apple AAPL 0.66% plans to do with it.

Read more